REFLUX ESOPHAGITIS (RE)

Clinical trials for REFLUX ESOPHAGITIS (RE) explained in plain language.

Never miss a new study

Get alerted when new REFLUX ESOPHAGITIS (RE) trials appear

Sign up with your email to follow new studies for REFLUX ESOPHAGITIS (RE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New heartburn pill aims to heal the burn

Disease control Recruiting now

This study is testing if a new drug called Anaprazole can heal damage in the esophagus caused by acid reflux and reduce symptoms like heartburn. It will compare Anaprazole to an existing medication (Rabeprazole) in 500 adults over 8 weeks. The main goal is to see if the new drug …

Matched conditions: REFLUX ESOPHAGITIS (RE)

Phase: PHASE3 • Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

REFLUX ESOPHAGITIS (RE)

Get alerted when new REFLUX ESOPHAGITIS (RE) trials appear

New heartburn pill aims to heal the burn